Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells.

Steele VE, Arnold JT, Lei H, Izmirlian G, Blackman MR.

Anticancer Res. 2006 Sep-Oct;26(5A):3205-15.

2.

Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.

Arnold JT, Le H, McFann KK, Blackman MR.

Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E573-84. Epub 2004 Nov 9.

4.
5.

Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo.

Chen Q, Watson JT, Marengo SR, Decker KS, Coleman I, Nelson PS, Sikes RA.

Cancer Lett. 2006 Dec 8;244(2):274-88. Epub 2006 Feb 23.

PMID:
16500022
6.

Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.

Waltering KK, Helenius MA, Sahu B, Manni V, Linja MJ, Jänne OA, Visakorpi T.

Cancer Res. 2009 Oct 15;69(20):8141-9. doi: 10.1158/0008-5472.CAN-09-0919. Epub 2009 Oct 6.

7.

Genome-wide analysis of DHEA- and DHT-induced gene expression in mouse hypothalamus and hippocampus.

Mo Q, Lu S, Garippa C, Brownstein MJ, Simon NG.

J Steroid Biochem Mol Biol. 2009 Apr;114(3-5):135-43. doi: 10.1016/j.jsbmb.2009.01.015. Epub 2009 Feb 3.

PMID:
19429443
8.

Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis.

Waghray A, Feroze F, Schober MS, Yao F, Wood C, Puravs E, Krause M, Hanash S, Chen YQ.

Proteomics. 2001 Oct;1(10):1327-38.

PMID:
11721644
9.

Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cells.

Bruckheimer EM, Spurgers K, Weigel NL, Logothetis C, McDonnell TJ.

J Urol. 2003 Apr;169(4):1553-7.

PMID:
12629413
10.

The synthetic estrogen diethylstilbestrol (DES) inhibits the telomerase activity and gene expression of prostate cancer cells.

Geier R, Adler S, Rashid G, Klein A.

Prostate. 2010 Sep 1;70(12):1307-12. doi: 10.1002/pros.21166.

PMID:
20623632
11.

Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells.

Zhu YS, Cai LQ, You X, Cordero JJ, Huang Y, Imperato-McGinley J.

J Androl. 2003 Sep-Oct;24(5):681-7.

12.

Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.

Singh AP, Bafna S, Chaudhary K, Venkatraman G, Smith L, Eudy JD, Johansson SL, Lin MF, Batra SK.

Cancer Lett. 2008 Jan 18;259(1):28-38. Epub 2007 Oct 30.

13.
14.

Identification of novel androgen receptor target genes in prostate cancer.

Jariwala U, Prescott J, Jia L, Barski A, Pregizer S, Cogan JP, Arasheben A, Tilley WD, Scher HI, Gerald WL, Buchanan G, Coetzee GA, Frenkel B.

Mol Cancer. 2007 Jun 6;6:39.

15.

Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.

Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.

Cancer Res. 2004 Oct 1;64(19):7156-68.

16.

Endothelin-1 production by prostate cancer cell lines is up-regulated by factors involved in cancer progression and down-regulated by androgens.

Granchi S, Brocchi S, Bonaccorsi L, Baldi E, Vinci MC, Forti G, Serio M, Maggi M.

Prostate. 2001 Dec 1;49(4):267-77.

PMID:
11746273
17.
18.

Dehydroepiandrosterone (DHEA) is an anabolic steroid like dihydrotestosterone (DHT), the most potent natural androgen, and tetrahydrogestrinone (THG).

Labrie F, Luu-The V, Martel C, Chernomoretz A, Calvo E, Morissette J, Labrie C.

J Steroid Biochem Mol Biol. 2006 Jul;100(1-3):52-8. Epub 2006 Jun 21.

PMID:
16797178
19.

[Effect of dihydrotestosterone on the transcriptions and expressions of Smad3 and Smad4 in LNCaP cell line].

Gu RG, Zhou CW, Ma QZ.

Zhonghua Nan Ke Xue. 2006 Mar;12(3):211-4. Chinese.

PMID:
16597033
20.

Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.

Chakrabarti R, Robles LD, Gibson J, Muroski M.

Cancer Genet Cytogenet. 2002 Dec;139(2):115-25.

PMID:
12550771

Supplemental Content

Support Center